Ad is loading...
DNA
Price
$7.18
Change
+$0.59 (+8.95%)
Updated
Nov 22 closing price
ZURA
Price
$2.73
Change
-$0.20 (-6.83%)
Updated
Nov 22 closing price
Ad is loading...

DNA vs ZURA

Header iconDNA vs ZURA Comparison
Open Charts DNA vs ZURABanner chart's image
Ginkgo Bioworks Holdings
Price$7.18
Change+$0.59 (+8.95%)
Volume$1.22M
CapitalizationN/A
Zura Bio
Price$2.73
Change-$0.20 (-6.83%)
Volume$523.12K
CapitalizationN/A
DNA vs ZURA Comparison Chart
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNA vs. ZURA commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a StrongBuy and ZURA is a StrongBuy.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (DNA: $7.18 vs. ZURA: $2.73)
Brand notoriety: DNA and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 102% vs. ZURA: 104%
Market capitalization -- DNA: $412.7M vs. ZURA: $178.25M
DNA [@Biotechnology] is valued at $412.7M. ZURA’s [@Biotechnology] market capitalization is $178.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than DNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 5 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 5 bullish, 5 bearish.
  • ZURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ZURA.

Price Growth

DNA (@Biotechnology) experienced а +12.72% price change this week, while ZURA (@Biotechnology) price change was -13.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

DNA is expected to report earnings on Nov 11, 2024.

ZURA is expected to report earnings on Mar 28, 2023.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($413M) has a higher market cap than ZURA($178M). ZURA YTD gains are higher at: -41.542 vs. DNA (-89.379). ZURA has higher annual earnings (EBITDA): -50.28M vs. DNA (-630.64M). DNA has more cash in the bank: 616M vs. ZURA (188M). DNA has higher revenues than ZURA: DNA (217M) vs ZURA (0).
DNAZURADNA / ZURA
Capitalization413M178M232%
EBITDA-630.64M-50.28M1,254%
Gain YTD-89.379-41.542215%
P/E RatioN/A7.96-
Revenue217M0-
Total Cash616M188M328%
Total Debt446MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DNAZURA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
54%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
51%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
61%
View a ticker or compare two or three
Ad is loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRJQX49.240.16
+0.33%
PGIM Jennison Global Opportunities R6
CCDVX18.400.04
+0.22%
Calamos Dividend Growth C
AIONX17.820.04
+0.22%
AQR International Momentum Style N
JFARX39.160.05
+0.13%
JHancock Fundamental All Cap Core R4
TEMHX8.21-0.01
-0.12%
Nuveen Emerging Markets Eq I

ZURA and

Correlation & Price change

A.I.dvisor tells us that ZURA and DNA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZURA and DNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-6.83%
DNA - ZURA
31%
Poorly correlated
+8.95%
UBX - ZURA
31%
Poorly correlated
-1.72%
NKTX - ZURA
29%
Poorly correlated
+0.41%
CGEM - ZURA
28%
Poorly correlated
+2.62%
BPMC - ZURA
27%
Poorly correlated
-2.56%
More